Core Insights - Immunocore Holdings PLC's stock price increased by 5.9% to $35.29, following a period of 7.9% loss over the past four weeks, indicating a significant recovery in trading volume [1] - The company's strategic priorities for 2026 focus on commercial expansion of its drug KIMMTRAK and advancements in clinical studies, including late-stage melanoma studies and new data on early-stage cancer and HIV [2] - The upcoming quarterly report is expected to show a loss of $0.28 per share, a 40.4% improvement year-over-year, with revenues projected at $107.83 million, reflecting a 28.3% increase from the previous year [3] - The consensus EPS estimate for the quarter has been revised 13% higher in the last 30 days, suggesting a positive trend that may lead to further stock price appreciation [4] - Immunocore holds a Zacks Rank of 1 (Strong Buy), indicating strong market confidence, while Avidity Biosciences, a peer in the same industry, has a lower Zacks Rank of 3 (Hold) [5][6] Company Performance - Immunocore's stock performance is bolstered by its strategic focus and positive earnings estimate revisions, which historically correlate with stock price movements [3][4] - The anticipated revenue growth and improved EPS estimates position Immunocore favorably within the biomedical and genetics industry [2][3] Industry Context - Immunocore is part of the Zacks Medical - Biomedical and Genetics industry, where it competes with companies like Avidity Biosciences, which has seen a negative revision in its EPS estimates [5][6]

Core Viewpoint - Steel Dynamics (STLD) is expected to report quarterly earnings of $1.72 per share, reflecting a 26.5% increase year-over-year, with revenues projected at $4.54 billion, a 17.2% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 0.4% in the last 30 days, indicating analysts' reassessment of their initial estimates [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue and Sales Projections - Analysts estimate 'External Net Sales- Steel Fabrication' to reach $362.78 million, a decrease of 8.4% from the year-ago quarter [5]. - 'External Net Sales- Steel' is projected at $3.21 billion, representing a 21.3% increase year-over-year [5]. - 'External Net Sales- Metals Recycling' is expected to be $471.84 million, a decline of 2.1% from the previous year [5]. - The consensus for 'External Net Sales- Other' is $317.61 million, indicating a 10.4% increase year-over-year [6]. Pricing and Shipment Metrics - The average external sales price for steel is projected at $1,092 per tonne, up from $1,011 per tonne a year ago [6]. - 'Steel Fabrication - Average sales price' is expected to be $2,558 per tonne, down from $2,718 per tonne in the same quarter last year [7]. - 'Steel - External Shipments' are forecasted to reach 2,939 thousand tons, compared to 2,618 thousand tons in the previous year [7]. - 'Steel Fabrication - Shipments' are estimated at 142 thousand tons, slightly down from 146 thousand tons year-over-year [8]. - 'Steel - Flat Roll shipments' are projected at 1,997 thousand tons, an increase from 1,842 thousand tons year-over-year [9]. - 'Metals Recycling - Ferrous shipments' are expected to be 1,440 thousand tons, compared to 1,421 thousand tons in the same quarter last year [9]. - 'Steel - Flat Roll shipments - Steel Processing Divisions' are estimated at 494 thousand tons, up from 460 thousand tons year-over-year [10]. Stock Performance - Steel Dynamics shares have decreased by 3% over the past month, while the Zacks S&P 500 composite has seen a decline of 0.4%. The company holds a Zacks Rank 2 (Buy), indicating expected outperformance in the near term [11].

Core Viewpoint - Analysts forecast that Midland States Bancorp (MSBI) will report quarterly earnings of $0.70 per share, reflecting a year-over-year increase of 127.8%, with anticipated revenues of $78.5 million, an increase of 3.8% compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised 4% higher over the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term price performance [3]. Key Metrics Forecast - Analysts expect 'Net Interest Margin' to be 3.7%, up from 3.2% in the same quarter last year [5]. - 'Net charge-offs to average loans' is forecasted to reach 3.0%, a significant decrease from 7.2% reported in the same quarter last year [5]. - The 'Efficiency Ratio' is expected to be 62.6%, down from 71.4% a year ago [5]. Financial Performance Indicators - The estimated 'Average Balance - Total interest-earning assets' is $6.27 billion, compared to $7.01 billion a year ago [6]. - 'Wealth management revenue' is projected to be $8.05 million, up from $7.66 million in the same quarter last year [6]. - 'Net Interest Income (FTE)/Adjusted net interest income' is expected to reach $58.03 million, compared to $56.26 million a year ago [7]. - 'Total Noninterest Income' is forecasted at $20.08 million, up from $19.56 million in the previous year [7]. Additional Revenue Estimates - 'Service charges on deposit accounts' are expected to be $3.83 million, compared to $3.51 million in the same quarter last year [8]. - The consensus estimate for 'Interchange revenue' stands at $3.23 million, down from $3.53 million a year ago [8]. Market Performance - Over the past month, Midland States Bancorp shares have recorded returns of +3.7%, while the Zacks S&P 500 composite has seen a -0.4% change, indicating potential outperformance in the upcoming period [8].

Group 1 - Silvercorp (SVM) shares rose 8.2% to $12.24 in the last trading session, with a notable trading volume, and have gained 26.8% over the past four weeks [1] - The increase in shares is attributed to Silvercorp's announcement of acquiring a 70% interest in Chaarat ZAAV CJSC, leading to a joint venture [1] - Silvercorp reported record third-quarter revenue of $126.1 million, a 51% year-over-year increase, supported by rising gold and silver prices due to geopolitical tensions [2] Group 2 - The expected quarterly earnings for Silvercorp are $0.17 per share, reflecting a 70% year-over-year increase, with revenues projected at $125.2 million, up 49.7% from the previous year [2] - The consensus EPS estimate for Silvercorp has been revised 27.3% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] - Silvercorp holds a Zacks Rank of 2 (Buy), indicating favorable market sentiment [5]

Group 1 - Scotts Miracle-Gro (SMG) is currently ranked 15 in the Zacks Sector Rank among 180 companies in the Consumer Staples group [2] - The Zacks Rank system, which focuses on earnings estimates and revisions, gives Scotts Miracle-Gro a Zacks Rank of 2 (Buy), indicating a positive earnings outlook [3] - Over the past three months, the Zacks Consensus Estimate for SMG's full-year earnings has increased by 0.8%, reflecting stronger analyst sentiment [4] Group 2 - Scotts Miracle-Gro has returned approximately 9.9% year-to-date, significantly outperforming the Consumer Staples sector average return of 2.1% [4] - Scotts Miracle-Gro belongs to the Agriculture - Operations industry, which has gained an average of 9.8% this year, indicating better performance compared to its industry peers [6] - In contrast, United Natural Foods (UNFI), another Consumer Staples stock, has increased by 4.6% year-to-date, with a Zacks Rank of 1 (Strong Buy) [5]

Core Viewpoint - Analysts forecast that Intel will report a quarterly earnings of $0.08 per share, reflecting a year-over-year decline of 38.5%, with revenues expected to be $13.37 billion, a decrease of 6.2% compared to the previous year [1]. Earnings Estimates - Over the last 30 days, there has been a downward revision of 13.2% in the consensus EPS estimate for the quarter, indicating a collective reconsideration by analysts of their initial forecasts [2]. - Changes in earnings estimates are crucial for predicting potential investor reactions, as empirical studies show a strong relationship between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts project 'Net Revenues- All other- Total' at $750.12 million, indicating a year-over-year change of -28% [5]. - The 'Net Revenues- Total Intel Products Group- Data Center and AI' is expected to reach $4.36 billion, suggesting a year-over-year increase of 28.8% [5]. - The 'Net Revenues- Total Intel Products Group- Client Computing Group' is estimated to be $8.33 billion, reflecting a 4% increase from the year-ago quarter [6]. - The consensus estimate for 'Net Revenues- Intel Foundry Services' stands at $4.39 billion, indicating a year-over-year decline of 2.4% [6]. - Overall, 'Net Revenues- Total Intel Products Group' is projected to be $12.68 billion, showing a year-over-year change of -2.7% [6]. Stock Performance - Intel shares have experienced a change of +33.2% in the past month, outperforming the +2% move of the Zacks S&P 500 composite [7]. - With a Zacks Rank 3 (Hold), Intel is expected to mirror the overall market performance in the near future [7].

Core Viewpoint - Analysts forecast that Cadence (CADE) will report quarterly earnings of $0.79 per share, reflecting a year-over-year increase of 12.9%, with anticipated revenues of $523.7 million, an increase of 16.2% compared to the previous year [1] Earnings Estimates - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating stability in analysts' assessments [1][2] Key Financial Metrics - Analysts project the 'Adjusted Efficiency Ratio fully tax equivalent' to reach 56.3%, down from 59.1% a year ago [4] - The 'Net Interest Margin' is expected to be 3.5%, slightly up from 3.4% in the previous year [4] - The 'Average Balance - Total interest earning assets' is projected to be $48.77 billion, an increase from $42.92 billion reported in the same quarter last year [4] Non-Performing Loans and Assets - The consensus estimate for 'Non-Performing Loans' is $251.17 million, down from $264.69 million a year ago [5] - Analysts predict 'Non-Performing Assets' to be $267.20 million, compared to $270.45 million last year [5] Income Projections - 'Total noninterest income' is expected to reach $96.18 million, up from $86.17 million in the same quarter of the previous year [5] - 'Net Interest Income' is projected at $427.67 million, an increase from $365.18 million a year ago [6] - The estimated 'Net Interest Income (FTE)' is $426.76 million, compared to $364.53 million last year [6] Other Income Sources - 'Credit card, debit card and merchant fees' are expected to be $13.82 million, up from $12.66 million last year [7] - 'Other noninterest income' is projected to reach $28.42 million, compared to $27.28 million in the same quarter last year [7] - 'Deposit Service charges' are expected to be $19.28 million, up from $18.69 million last year [8] - 'Mortgage banking' is projected to arrive at $6.80 million, significantly up from $3.55 million in the same quarter last year [8] Stock Performance - Shares of Cadence have experienced a change of +2.3% in the past month, compared to a +2% move of the Zacks S&P 500 composite, indicating a performance in line with the overall market [9]

Core Viewpoint - Huntington Bancshares (HBAN) is expected to report quarterly earnings of $0.39 per share, reflecting a 14.7% increase year-over-year, with revenues projected at $2.21 billion, a 12.3% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised 0.6% higher in the last 30 days, indicating analysts' positive reevaluation of their initial projections [2]. - Prior to earnings releases, revisions to earnings projections are crucial for predicting investor behavior, as studies show a strong correlation between earnings estimate trends and short-term stock performance [3]. Key Financial Metrics - Analysts project the 'Efficiency Ratio' to be 57.8%, down from 58.6% a year ago [5]. - The 'Net Interest Margin (FTE)' is expected to reach 3.2%, up from 3.0% in the same quarter last year [5]. - The 'Average Balance - Total earning assets' is estimated at $203.09 billion, compared to $185.22 billion in the same quarter of the previous year [6]. - The 'Tier 1 Leverage Ratio' is forecasted at 8.9%, up from 8.6% a year ago, while the 'Regulatory Tier 1 risk-based capital ratio' is expected to be 12.7%, compared to 11.9% last year [6]. Income Projections - 'Net interest income - FTE' is projected to reach $1.61 billion, compared to $1.41 billion in the same quarter last year [7]. - 'Total Non-Interest Income' is estimated at $601.80 million, up from $559.00 million a year ago [7]. - 'Capital markets and advisory fees' are expected to be $104.27 million, down from $120.00 million last year [8]. - 'Customer deposit and loan fees' are projected at $105.42 million, compared to $88.00 million last year [8]. - 'Payments and cash management revenue' is expected to be $177.18 million, up from $162.00 million last year [9]. - 'Wealth and asset management revenue' is projected at $105.54 million, compared to $93.00 million last year [9]. - 'Mortgage banking income' is expected to reach $35.53 million, up from $31.00 million in the same quarter last year [10]. Stock Performance - Over the past month, shares of Huntington Bancshares have returned +2.1%, slightly outperforming the Zacks S&P 500 composite's +2% change [11]. - Currently, HBAN holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [11].

Core Viewpoint - Procter & Gamble (PG) is expected to report quarterly earnings of $1.87 per share, reflecting a year-over-year decline of 0.5%, with revenues projected at $22.23 billion, an increase of 1.6% compared to the previous year [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised downward by 0.1%, indicating a collective reassessment by analysts [2]. - Revisions to earnings estimates are significant indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue and Sales Projections - Analysts estimate 'Net Sales- Beauty' will reach $4.00 billion, a change of +3.8% from the prior-year quarter [5]. - 'Net Sales- Grooming' is projected at $1.81 billion, indicating a +3.1% change from the year-ago quarter [5]. - 'Net Sales- Corporate' is expected to be $166.23 million, reflecting a +4.6% change from the previous year [5]. - 'Net Sales- Fabric & Home Care' is anticipated to reach $7.70 billion, a +1.7% change from the prior-year quarter [6]. - 'Net Sales- Baby, Feminine & Family Care' is projected at $5.30 billion, showing a +0.1% change from the year-ago quarter [6]. - 'Net Sales- Health Care' is estimated at $3.32 billion, indicating a +2.1% change from the previous year [7]. Organic Sales Growth - The overall 'Organic Sales Growth (YoY change) - Total P&G' is expected to be 0.4%, down from 3.0% in the previous year [7]. - 'Organic Sales Growth (YoY change) - Baby, Feminine & Family Care' is forecasted at -1.9%, compared to 4.0% last year [7]. - 'Organic Sales Growth (YoY change) - Fabric & Home Care' is estimated at 0.2%, down from 3.0% in the prior year [8]. - The consensus for 'Organic Sales Growth (YoY change) - Health Care' stands at 1.2%, compared to 3.0% reported in the same quarter last year [8]. Earnings Before Income Taxes - 'Earnings before income taxes- Beauty' is expected to be $1.07 billion, compared to $996.00 million in the previous year [9]. - 'Earnings before income taxes- Grooming' is projected at $577.96 million, up from $568.00 million reported last year [9]. Stock Performance - Over the past month, P&G shares have recorded a return of -0.6%, while the Zacks S&P 500 composite has increased by +2% [9].

Core Viewpoint - Analysts project that McCormick (MKC) will report quarterly earnings of $0.88 per share, reflecting a 10% year-over-year increase, with revenues expected to reach $1.85 billion, a 2.6% increase from the same quarter last year [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate for the quarter has been revised downward by 2.9%, indicating a collective reassessment by covering analysts [2]. - Revisions to earnings estimates are crucial indicators for predicting potential investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Key Metrics Forecast - Analysts predict 'Net Sales- Flavor Solutions' will reach $725.28 million, representing a year-over-year change of +1.7% [5]. - The estimated 'Net Sales- Consumer' is projected at $1.12 billion, indicating a year-over-year change of +2.8% [5]. - 'Operating income excluding special charges and transaction and integration expenses- Flavor Solutions' is expected to reach $93.29 million, up from $80.00 million in the previous year [6]. - 'Operating income excluding special charges and transaction and integration expenses- Consumer' is projected at $241.22 million, compared to $228.00 million last year [6]. Stock Performance - McCormick shares have experienced a +0.4% change over the past month, while the Zacks S&P 500 composite has moved +2% [7]. - With a Zacks Rank 2 (Buy), McCormick is expected to outperform the overall market in the near future [7].